title: American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary.
authors.forename: Paul S
authors.initials: PS
authors.lastname: Jellinger
authors.forename: Donald A
authors.initials: DA
authors.lastname: Smith
authors.forename: Adi E
authors.initials: AE
authors.lastname: Mehta
authors.forename: Om
authors.initials: O
authors.lastname: Ganda
authors.forename: Yehuda
authors.initials: Y
authors.lastname: Handelsman
authors.forename: Helena W
authors.initials: HW
authors.lastname: Rodbard
authors.forename: Mark D
authors.initials: MD
authors.lastname: Shepherd
authors.forename: John A
authors.initials: JA
authors.lastname: Seibel
mesh_terms: D000293:Adolescent; D000328:Adult; D050197:Atherosclerosis / Q000191:economics / Q000209:etiology / Q000517:prevention & control*; D002648:Child; D003131:Combined Modality Therapy / Q000191:economics; D017046:Cost Savings; D018752:Diet, Fat-Restricted; D016903:Drug Monitoring; D050171:Dyslipidemias / Q000191:economics / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D017048:Health Care Costs; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D007333:Insulin Resistance; D008055:Lipids / Q000097:blood; D008297:Male; D009043:Motor Activity; D012307:Risk Factors; D016540:Smoking Cessation; D014481:United States / Q000453:epidemiology
chemical_list: D000960:Hypolipidemic Agents; D008055:Lipids